Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Seokhyeong Go"'
Autor:
Jihye Hong, Mungyo Jung, Cheesue Kim, Mikyung Kang, Seokhyeong Go, Heesu Sohn, Sangjun Moon, Sungpil Kwon, Seuk Young Song, Byung-Soo Kim
Publikováno v:
Experimental and Molecular Medicine, Vol 55, Iss 3, Pp 541-554 (2023)
Cancer: Turning tumors into vaccines Therapeutic vaccines derived from tumor cells could provide a personalized strategy for training the immune system to find and destroy cancer. Past efforts to develop such vaccines have been hampered by the challe
Externí odkaz:
https://doaj.org/article/99e7cb4791924948aa38bb75651f5dd4
Publikováno v:
Tissue Engineering and Regenerative Medicine. 20:389-409
Autor:
Cheesue Kim, Seul-Gee Lee, Songhyun Lim, Mungyo Jung, Sung Pil Kwon, Jihye Hong, Mikyung Kang, Hee Su Sohn, Seokhyeong Go, Sangjun Moon, Seung-Jun Lee, Jung-Sun Kim, Byung-Soo Kim
Publikováno v:
ACS Biomaterials Science & Engineering. 8:1921-1929
The vast majority of drug-eluting stents (DES) elute either sirolimus or one of its analogues. While limus drugs stymie vascular smooth muscle cell (VSMC) proliferation to prevent in-stent restenosis, their antiproliferative nature is indiscriminate
Publikováno v:
Tissue Eng Regen Med
BACKGROUND: Ferroptosis is an iron-dependent, non-apoptotic programmed cell death. Cellular senescence contributes to aging and various age-related diseases through the expression of a senescence-associated secretory phenotype (SASP). Senescent cells
Autor:
Jihye Hong, Seokhyeong Go, Han Young Kim, Yeon Woong Choo, Seuk Young Song, Mikyung Kang, Sung Pil Kwon, Hee Su Sohn, Byung-Soo Kim
Publikováno v:
Nano Letters. 19:5185-5193
Liposomes are clinically used as drug carriers for cancer therapy; however, unwanted leakage of the encapsulated anticancer drug and poor tumor-targeting efficiency of liposomes may generate toxic side effects on healthy cells and lead to failure of
Autor:
Yeon Woong Choo, Seuk Young Song, Ju-Ro Lee, Mungyo Jung, Sung Pil Kwon, Han Young Kim, Jin Han, Byung-Soo Kim, Jihye Hong, Gun-Jae Jeong, Seokhyeong Go, Seokyung Kang, Mikyung Kang
Publikováno v:
ACS Nano. 12:8977-8993
Cancer immunotherapy modulates immune cells to induce antitumor immune responses. Tumors employ immune checkpoints to evade immune cell attacks. Immune checkpoint inhibitors such as anti-PD-L1 antibody (aPD-L1), which is being used clinically for can
Publikováno v:
ACS Biomaterials Science & Engineering. 4:2571-2581
Stem cell therapy has great potential for the treatment of ischemic diseases, but poor engraftment of implanted stem cells limits the therapeutic efficacy. Here, we developed an approximately 80 μm injectable decellularized matrix (IDM) to increase
Autor:
Yu-Kyoung Oh, Dongyoon Kim, Sagang Koo, Mikyung Kang, Mungyo Jung, Junho Byun, Hee Ho Park, Sung Pil Kwon, Jihye Hong, Seuk Young Song, Seokhyeong Go, Cheesue Kim, Miji Kwon, Byung-Soo Kim, Jae Hyun Choi, Sangjun Moon, Taeghwan Hyeon, Seong Ho Lee
Publikováno v:
Advanced Materials. 33:2103258
Chimeric antigen receptor-T (CAR-T) cell immunotherapy has shown impressive clinical outcomes for hematologic malignancies. However, its broader applications are challenged due to its complex ex vivo cell-manufacturing procedures and low therapeutic
Autor:
Hee Su Sohn, Jihye Hong, Seokhyeong Go, Nathaniel S. Hwang, Mikyung Kang, Seungmi Ryu, Seung Hyun Kim, Byung-Soo Kim, Gun-Jae Jeong, Ju-Ro Lee, Seuk Young Song, Kookheon Char, Jin Yoo
Publikováno v:
Theranostics
Rationale: Cardiovascular diseases often cause substantial heart damage and even heart failure due to the limited regenerative capacity of adult cardiomyocytes. The direct cardiac reprogramming of fibroblasts could be a promising therapeutic option f